Videos de Experimentos Relacionados
Trombólisis farmacológica: activador de plasminógeno de tipo tejido.
Circulation
|August 1, 1987
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.
Proceedings of the Association of American Physicians·1999
Insulin resistance and thrombosis: a cardiologist's view.
The American journal of cardiology·1999
TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.
The American journal of physiology·1999
Cardiovascular consequences of polycystic ovary syndrome.
Endocrinology and metabolism clinics of North America·1999
Cardiovascular Risk Reduction With GLP-1 RA Drugs.
Circulation·2026
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.
Science translational medicine·2026
Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.
Diabetes, obesity & metabolism·2026
Ameliorative Effects of <i>Spirulina platensis</i> Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.
Foods (Basel, Switzerland)·2026
Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.
Naunyn-Schmiedeberg's archives of pharmacology·2026